SR

Siva Rama Prasad Darsi

Active Director Director DIN 10462036
DIN 10462036 First appointment Jan 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Siva Rama Prasad Darsi

Data last updated:

Siva Rama Prasad Darsi is a Director at Renovocell Biologics Private Limited (since 2024). The company operates in Paper.

DIN 10462036
Primary Designation Director
Industry Paper
First Appointment 11 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Renovocell Biologics Private Limited U21001TS2024PTC180955
Director11 Jan 20242024Active

Board colleagues of Siva Rama Prasad Darsi

Directorship timeline

Open interactive timeline →
Renovocell Biologics Private Limited
Premium access

Shareholding and investment profile for Siva Rama Prasad Darsi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siva Rama Prasad Darsi

Siva Rama Prasad Darsi currently holds 1 directorship: Renovocell Biologics Private Limited (Director, since 11 Jan 2024).

Siva Rama Prasad Darsi was first appointed on 11 Jan 2024 as Director at Renovocell Biologics Private Limited.

The current boards of Siva Rama Prasad Darsi's companies include Devaiah Pagidipati (Renovocell Biologics Private Limited), Ravi Kumar Vendra (Renovocell Biologics Private Limited), Satyanarayana Gowtham Guttula (Renovocell Biologics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available